Frontier Medicines’ integrated approach leverages chemoproteomics and machine learning to accelerate the development of medicines that drug the “undruggable” protein targets that drive human disease.
Frontier Medicines is discovering and developing breakthrough medicines that redefine the course of debilitating diseases.
Press Releases
Frontier Medicines to Present at the 39th Annual J.P. Morgan Healthcare Conference
more
more